Position in QGEN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$158,706
+$153,221 QoQ
Shares Held
4,059
+2862.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#240
of 332 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $42,339,129 across 32 Diagnostics & Research names. QGEN ranks #17 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
56,486 | $9,931,933 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
12,159 | $6,096,036 | |
| 3 | NTRA |
Natera, Inc.
|
18,839 | $5,113,846 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
23,532 | $4,546,853 | |
| 5 | DHR |
Danaher Corp /De/
|
22,030 | $4,196,274 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
6,259 | $3,314,703 | |
| 7 | A |
Agilent Technologies, Inc.
|
19,198 | $2,550,070 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
1,735 | $913,373 |
All Filings in QGEN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $158,706 | 4,059 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $5,485 | 137 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $17,448 | 388 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $100,217 | 2,243 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,005 | 229 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $7,391 | 166 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $11,346 | 249 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $10,231 | 249 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||